Soc. Generale Call 13 1U1 21.06.2.../ DE000SV25WH9 /
30/05/2024 21:47:47 | Chg.+0.120 | Bid21:59:36 | Demandez à21:59:36 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
4.240EUR | +2.91% | 4.190 Bid taille: 800 |
4.730 Ask la taille: 800 |
1+1 AG INH O.N. | 13.00 - | 21/06/2024 | Call |
GlobeNewswire
22:05
Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
22:05
IndyCar Driver Marcus Armstrong to Represent Root Insurance at Detroit Grand Prix
GlobeNewswire
22:05
Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of P...
GlobeNewswire
22:05
Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedr...
GlobeNewswire
22:05
Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
GlobeNewswire
22:05
Oncternal Announces Enrollment Completed and Dosing Initiated for Fifth Dose Cohort of Phase 1/2 Stu...
GlobeNewswire
22:05
Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affa...
GlobeNewswire
22:05
BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq ...
GlobeNewswire
22:05
NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
GlobeNewswire
22:05
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
GlobeNewswire
22:03
PATH (NYSE) INVESTIGATION ALERT: BFA Law Announces Investigation into UiPath, Inc., Encourages Inves...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page